Ultra-performance Liquid Chromatography / Mass Spectrometry (UPLC/MS)
Monitoring fluconazole therapy to guide dose adjustment and ensure adequate coverage while avoiding high concentrations associated with toxicity, especially in patients who have severely compromised renal function, for those who are undergoing dialysis, or for those where absorption may be impacted. Routine drug monitoring is not indicated in most patients.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
2 - 3 days
Test sent to Mayo Medical Laboratories; performed by UT Health Science Center at San Antonio.